Resources

Selected
  • SAGE documentation
  • Dengue
Type of publications
Topics
Diseases
Publication date
Available to download in languages

13 results found

2024 ∙ SAGE

Dengue Vaccine (TAK-003) GRADE tables

  • GRADE table
  • Qdenga
  • Dengue
Download:
2024 ∙ SAGE

Dengue Evidence to Recommendation

  • Evidence to recommendation table
  • Qdenga
  • Dengue
Download:
2024 ∙ SAGE

WHO position paper on dengue vaccines – May 2024

  • Position paper
  • Qdenga
  • Dengue
Download:
2023 ∙ SAGE

Meeting of the Strategic Advisory Group of Experts on Immunization, September 2023: conclusions and recommendations

  • Meeting report
  • Dengue
  • Poliomyelitis
  • Smallpox
  • Malaria
  • COVID-19
  • Mumps
  • Cholera
Download:
2018 ∙ SAGE

What is the efficacy of 3 doses of CYD-TDV in preventing clinical dengue in seronegative individuals 9-16 years of age in the first year following vaccination?

  • GRADE table
  • Dengue
Download:
2018 ∙ SAGE

What is the efficacy of 3 doses of CYD-TDV in preventing clinical dengue in seropositive individuals 9-16 years of age in the first year following vaccination?

  • GRADE table
  • Dengue
Download:
2018 ∙ SAGE

Should countries considering introduction of CYD-TDV to reduce the burden of dengue use a pre-vaccination screening or population seroprevalence based criteria?

  • Evidence to recommendation table
  • Dengue
Download:
2018 ∙ SAGE

Should CYD-TDV be recommended, over no vaccination, to immunocompetent individuals (≥9 years of age) in dengueendemic countries to mitigate the dengue burden of disease?

  • Evidence to recommendation table
  • Dengue
Download:
2018 ∙ SAGE

What is the duration of protection/risk in seropositive individuals 9-16 years of age vaccinated with CYD-TDV?

  • GRADE table
  • Dengue
Download:
2018 ∙ SAGE

What is the duration of protection/risk in seronegative individuals 9-16 years of age vaccinated with CYD-TDV?

  • GRADE table
  • Dengue
Download:
Loading...